Journal
FRONTIERS IN PHARMACOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.735044
Keywords
sirtuin; inhibitor; activator; cancer; neurodeganaration; cardiovacsular diseases; SIRT1; SIRT2
Categories
Funding
- NIH/NCI [CA 223534]
- Falk Medical Research Foundation [MCG-18448-20]
Ask authors/readers for more resources
Sirtuins utilize NAD(+) to regulate cellular functions, are implicated in various human diseases, and thus the development of sirtuin modulators is of significant importance.
Sirtuins use NAD(+) to remove various acyl groups from protein lysine residues. Through working on different substrate proteins, they display many biological functions, including regulation of cell proliferation, genome stability, metabolism, and cell migration. There are seven sirtuins in humans, SIRT1-7, each with unique enzymatic activities, regulatory mechanisms, subcellular localizations, and substrate scopes. They have been indicated in many human diseases, including cancer, neurodegeneration, microbial infection, metabolic and autoimmune diseases. Consequently, interests in development of sirtuin modulators have increased in the past decade. In this brief review, we specifically summarize genetic and pharmacological modulations of sirtuins in cancer, neurological, and cardiovascular diseases. We further anticipate this review will be helpful for scrutinizing the significance of sirtuins in the studied diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available